Biopharmaceutical News and Research

RSS
Ventana partners with Incyte to develop companion diagnostic tests for oncology drug programs

Ventana partners with Incyte to develop companion diagnostic tests for oncology drug programs

5 Nov 2013
BioLineRx obtains regulatory approval to initiate BL-7010 Phase 1/2 trial for celiac disease

BioLineRx obtains regulatory approval to initiate BL-7010 Phase 1/2 trial for celiac disease

4 Nov 2013
Novaquest closes $459 million private equity fund

Novaquest closes $459 million private equity fund

31 Oct 2013
Alkermes reports 38% of year-over-year revenue growth from key products

Alkermes reports 38% of year-over-year revenue growth from key products

31 Oct 2013
3Sbio acquires patents for DJ5 to delay hereditary renal disease in ADPKD patients

3Sbio acquires patents for DJ5 to delay hereditary renal disease in ADPKD patients

29 Oct 2013
Cytrx announces Q3 2013 financial results, provides clinical update

Cytrx announces Q3 2013 financial results, provides clinical update

29 Oct 2013
Alimera Sciences receives Complete Response Letter for New Drug Application from FDA

Alimera Sciences receives Complete Response Letter for New Drug Application from FDA

19 Oct 2013
Stem Cell Therapeutics Nabs Sirpa Protein-Targeting Mabs

Stem Cell Therapeutics Nabs Sirpa Protein-Targeting Mabs

18 Oct 2013
Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

18 Oct 2013
Stem Cell Therapeutics Nabs Sirpa Protein-Targeting Mabs

Stem Cell Therapeutics Nabs Sirpa Protein-Targeting Mabs

17 Oct 2013
Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

17 Oct 2013
Imaxio Sells Genomics Division To Hybrigenics

Imaxio Sells Genomics Division To Hybrigenics

16 Oct 2013
SAGE Therapeutics obtains $20M Series B financing from two investors

SAGE Therapeutics obtains $20M Series B financing from two investors

16 Oct 2013
Innate Immunotherapeutics moves operations over to Sydney, Australia

Innate Immunotherapeutics moves operations over to Sydney, Australia

15 Oct 2013
immatics biotechnologies closes €34 million Series D financing round

immatics biotechnologies closes €34 million Series D financing round

15 Oct 2013
Crown Bioscience enters into collaboration with Xstrahl for radiation biology research

Crown Bioscience enters into collaboration with Xstrahl for radiation biology research

From Xstrahl 15 Oct 2013
Auxilium Pharmaceuticals gets exclusive right to market VIVUS's STENDRA in the US and Canada

Auxilium Pharmaceuticals gets exclusive right to market VIVUS's STENDRA in the US and Canada

11 Oct 2013
Constellation Pharmaceuticals awarded grant to facilitate study of epigenetic control of inflammation

Constellation Pharmaceuticals awarded grant to facilitate study of epigenetic control of inflammation

10 Oct 2013
Molecular Templates secures $8.5M series C financing plus $10.6M grant from CPRIT

Molecular Templates secures $8.5M series C financing plus $10.6M grant from CPRIT

9 Oct 2013
New method for improving cord blood transplant success

New method for improving cord blood transplant success

9 Oct 2013

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback